Complementary hypotheses in safety surveillance
From MaRDI portal
Publication:4965656
DOI10.1080/07474946.2020.1823195zbMATH Open1461.62196OpenAlexW3118597639MaRDI QIDQ4965656FDOQ4965656
Publication date: 9 March 2021
Published in: Sequential Analysis (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1080/07474946.2020.1823195
Recommendations
- A maximized sequential probability ratio test for drug and vaccine safety surveillance
- Continuous post-market sequential safety surveillance with minimum events to signal
- scientific article; zbMATH DE number 1154646
- Continuous versus group sequential analysis for post-market drug and vaccine safety surveillance
- Type I error probability spending for post-market drug and vaccine safety surveillance with Poisson data
Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical design (62L05) Sequential statistical analysis (62L10) Compound decision problems in statistical decision theory (62C25)
Cites Work
- Title not available (Why is that?)
- Sequential Tests of Statistical Hypotheses
- A Maximized Sequential Probability Ratio Test for Drug and Vaccine Safety Surveillance
- Title not available (Why is that?)
- ON A METHOD OF ESTIMATING FREQUENCIES
- Power, sample size and adaptation considerations in the design of group sequential clinical trials
- Title not available (Why is that?)
- Continuous versus group sequential analysis for post-market drug and vaccine safety surveillance
- Type I error probability spending for post-market drug and vaccine safety surveillance with Poisson data
- On a method of estimating frequencies
- One-Sided Tests in Clinical Trials with Multiple Endpoints
- Planning and Monitoring of Equivalence Studies
- Closed sequential tests for binomial probabilities
This page was built for publication: Complementary hypotheses in safety surveillance
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4965656)
